Tufts Health Plan provides positive coverage decision and in-network provider status

[News]

bioTheranostics, a leading provider of molecular diagnostic solutions for cancer, has received a positive coverage decision and in-network provider status from Tufts Health Plan for its CancerTYPE ID molecular cancer classifier.

More... (http://www.news-medical.net/news/20130823/Tufts-Health-Plan-provides-positive-coverage-decision-and-in-network-provider-status-to-bioTheranostics.aspx)